| Recommendation for Immunization |
|---|
Age: How often: | 6+ months Annual |
| Time of Year: | September-February |
Note: The optimal time to get the flu vaccine is October-November. This vaccine is optional for healthy people age 19-49, except for health care workers, household contacts of those at increased risk, and women who may be pregnant during the flu season. It is recommended that children 6 months to 8 years of age who have never received a flu vaccine get 2 vaccines and start in September. Children 6 months to 8 years of age who received a single vaccine dose in their first year of immunization should receive 2 doses the following year. |
Available brands of this vaccine include:
- Fluzone® (approved for individuals ages 6 months and over)
- Fluvirin® (approved for individuals ages 4 and over)
- Fluarix® (approved for individuals ages 18 and over)
- Afluria® (approved for individuals ages 18 and over)
- FluLavalTM (approved for individuals ages 18 and over)
- Flumist© (live attenuated nasal mist version; approved for individuals ages 2 to 49)
1. What is this vaccine?
This is an immunization to prevent influenza infection. There are actually 2 different kinds of flu immunization: an inactivated shot and a live, attenuated nasal mist. These immunizations have to be altered annually to anticipate the flu strains which are projected to be a threat in the coming flu season.
2. Why is this vaccine important?
Influenza, the "flu," is an unpleasant virus and in some cases can lead to complications, including pneumonia. By immunizing yourself against the disease, you are effectively minimizing your risk of contracting the virus. By receiving the vaccine, you can also prevent spreading it to others in your environment who may be at greater risk of complications. People with certain health conditions or extremes of age are at greater risk. Since the virus can mutate frequently, the vaccine is modified each year and is designed to immunize against the 3 strains of the virus expected to cause illness in the coming season.
3. How is this vaccine given?
For most people, the vaccine is a single shot of inactivated flu vaccine given in the deltoid muscle of the upper arm. Infants 6-12 months are usually injected in the upper outer thigh. Children aged 8 and under get a booster shot 1 month after the first shot if they have never had a flu shot before. Children 6 months to 8 years of age who received a single vaccine dose in their first year of immunization should receive 2 doses the following year.
There is also a nasal spray vaccine preparation called FluMist©. The FluMist© contains a live, but weakened virus.
4. What are the risks and special considerations of this vaccine?
Severe reactions, including life-threatening allergic reactions, can occur but are very rare. Rare cases of Guillain-Barré have occured, but causality has not been proven. Mild reactions can include soreness, swelling or redness at the injection site, aches, fever, nasal congestion, cough, headache, chills, sore throat, fatigue, muscle ache, fever, abdominal pain, vomiting, or diarrhea.
The influenza inactivated vaccine shot and FluMist© are not recommended for people with a fever, a history of Guillain-Barré syndrome, chicken or egg protein allergy, or a history of moderate or severe reaction to a flu shot. While pregnant women may receive the inactivated flu shot, some physicians prefer waiting until after the first 3 months of pregnancy. The inactivated flu shot is safe for breastfeeding women.
FluMist© is not recommended for those who are pregnant (even beyond 3 months), nursing, or generally unwell, or for children or teenagers on long-term aspirin therapy. It is not recommended for children under 2 years of age or adults 50 years or older. Because FluMist© contains a live virus, it is not recommended for anyone who might be at high risk for complications from influenza. This includes people with asthma, wheezing, other chronic lung or heart disease, diabetes, kidney failure, or weakened immunity. In addition, it is preferred not to use FluMist© for anyone caring for someone with severe immune problems because of the risk of transmitting the live vaccine virus to that individual.
While the vaccine is optional for healthy people ages 19 to 49 years, the influenza inactivated shot is recommended for people in this age range with certain health issues including: compromised immunity, HIV, diabetes, heart disease, chronic lung disease, chronic alcoholism, lack of speen, chronic liver disease, and chronic kidney disease. It is also recommended for women who will be pregnant during flu season, health-care personnel, and other individuals if they are caring for people at increased risk for influenza and its complications. Health-care personnel may receive either type of flu vaccine, but again, FluMist© should be avoided in people caring for immune compromised individuals.
Individuals with prior severe reactions to this vaccine may not be able to receive another dose. Check with your doctor regarding this issue and for any other contraindications for this vaccine. Also check with your doctor to find out what other ingredients may be in the vaccine, its container, or any diluent in case of allergies or other concerns. Immunization is usually postponed for individuals with a moderate or severe acute illness. Remember that this immunization can only protect against the flu strains covered by the vaccine, not against others strains and other respiratory illnesses.
5. Risk factors for contraction of disease
- >/= 50 years old
- Chronic heart, kidney, lung, liver, diabetes, cancer, HIV or blood disease
- Immune problems
- Chronic steroids
- Expecting to be 2nd or 3rd trimester pregnancy during flu season
- Long-term aspirin therapy in children 6 months-18 years
- Children 6-9 months
- Persons who cannot handle respiratory secretions such as those with certain brain or spinal cord injuries
- Residents of nursing homes, dormitories, or other crowded facilities
Citations
- "Preventative Screening Tests and Immunizations." U.S. Department of Health and Human Services. November 2007. www.4woman.gov/screeningcharts/general/.
- "Preventive Screening Tests and Immunizations." U.S. Department of Health and Human Services. June 2007. www.4woman.gov/screeningcharts/men/.
- "Recommended Immunization Schedule for Persons Aged 0-18 Years, United States 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. May 2008. http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2008/08_11x17_booklet_pr.pdf.
- "Recommended Adult Immunization Schedule — United States, October 2007–September 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. October 2007. www.cdc.gov/mmwr/pdf/wk/mm5641-Immunization.pdf.
- "Vaccine Information Statement. Inactivated Influenza Vaccine." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. July 2008. www.cdc.gov/vaccines/pubs/vis/downloads/vis-flu.pdf.
- "Vaccine Information Statement. Live, Attenuated Influenza Vaccine." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. July 2008. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-flulive.pdf.
- "Influenza Vaccine." Medline Plus. A Service of the U.S. National Library of Medicine and the National Institutes of Health. October 2007. http://www.nlm.nih.gov/medlineplus/ency/article/002025.htm.
- "Flu Vaccine News." FFF Enterprises. 2008. www.fffenterprises.com/FluVaccine/Index.aspx.
- "Highlights of Prescribing Information: Flumist® Influenza Virus Vaccine Live, Intranasal. 2008-2009 Formula." Food and Drug Administration. June 2008. http://www.fda.gov/cber/label/flumistLB.pdf.
- "Vaccine Excipient and Media Summary." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-1.pdf.
- "Vaccine Excipient and Media Summary, Part 2." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. April 2008. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf.
- "Questions & Answers: The Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV])." Centers for Disease Control and Prevention. July 2008. www.cdc.gov/flu/about/qa/nasalspray.htm.
- "Afluria®." CSL Biotherapies. June 2008. www.afluria.com/docs/PI.pdf.
- "Influenza Virus Vaccine Fluarix® 2007-2008 Formula." GlaxoSmithKline. 2008. http://us.gsk.com/products/assets/us_fluarix.pdf.
- "FluLavalTM." GlaxoSmithKline. 2008. us.gsk.com/products/assets/us_flulaval.pdf.
- "Fluvirin®." Novartis. Food & Drug Administration. July 2008. www.fda.gov/cber/label/fluvirinLB.pdf.
- "Highlights of Prescribing Information: Fluzone® (Influenza Virus Vaccine). Suspension for Intramuscular Injection." Food and Drug Administration. June 2008. http://www.fda.gov/cber/label/fluzoneLB.pdf.
- "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008." Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. July 2008. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e717a1.htm.
- "Thimerosal in Vaccines." Food and Drug Administration. June 2008. http://www.fda.gov/CbER/vaccine/thimerosal.htm.
Created: 7/2/2007
Last Modified: 8/18/2008